Issue 2/2018
Content (15 Articles)
Management of unresectable, locally advanced pancreatic adenocarcinoma
M. Salgado, S. Arévalo, O. Hernando, A. Martínez, R. Yaya, M. Hidalgo
Key points to optimizing management and research on cancer-associated thrombosis
A. Carmona-Bayonas, M. Sánchez-Cánovas, J. M. Plasencia, A. Custodio, E. Martínez de Castro, J. A. Virizuela, F. Ayala de la Peña, P. Jiménez-Fonseca
The potential roles of bacteria to improve radiation treatment outcome
E. Kouhsari, A. Ghadimi-Daresajini, H. Abdollahi, N. Amirmozafari, S. R. Mahdavi, S. Abbasian, S. H. Mousavi, H. F. Yaseri, M. Moghaderi
Long-term clinical benefit from salvage EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer patients with EGFR wild-type tumors
F. Koinis, A. Voutsina, A. Kalikaki, A. Koutsopoulos, E. Lagoudaki, E. Tsakalaki, E. K. Dermitzaki, E. Kontopodis, A. G. Pallis, V. Georgoulias, A. Kotsakis
Quality of life after whole brain radiotherapy compared with radiosurgery of the tumor bed: results from a randomized trial
L. Kepka, D. Tyc-Szczepaniak, K. Osowiecka, A. Sprawka, B. Trąbska-Kluch, B. Czeremszynska
MRI-guided radiotherapy for head and neck cancer: initial clinical experience
A. M. Chen, S. Hsu, J. Lamb, Y. Yang, N. Agazaryan, M. L. Steinberg, D. A. Low, M. Cao
Characteristics of adverse drug reactions in a vemurafenib early post-marketing phase vigilance study in Japan
H. Uhara, Y. Kiyohara, A. Tsuda, M. Takata, N. Yamazaki
Clinicopathologic parameters associated with postoperative complications and risk factors for tumor recurrence and mortality after tumor resection of patients with colorectal cancer
Z. Bai, J. Wang, T. Wang, Y. Li, X. Zhao, G. Wu, Y. Yang, W. Deng, Z. Zhang
Adjuvant versus salvage radiotherapy in prostate cancer: multi-institutional retrospective analysis of the Spanish RECAP database
A. Hervás, A. Gómez-Caamaño, M. Casaña, A. Gómez-Iturriaga, J. Pastor, J. Jove, J. L. Mengual, C. Gónzalez-San Segundo, J. Muñoz
Cancer survival in adult patients in Spain. Results from nine population-based cancer registries
M. D. Chirlaque, D. Salmerón, J. Galceran, A. Ameijide, A. Mateos, A. Torrella, R. Jiménez, N. Larrañaga, R. Marcos-Gragera, E. Ardanaz, M. Sant, P. Minicozzi, C. Navarro, M. J. Sánchez, Antonio Mateos, Enrique Almar, José Ramón Quirós, Marcial V. Argüelles, Virginia Menéndez, Dolores Rojas, Araceli Alemán, Ana Torrella, Consol Sabater, Paloma Botella, Matilde Chico, María Ripoll, Cristina Díaz, Marisa Vicente, Nieves Fuster, Paloma Botella, José María Díaz, Rosario Jiménez, Ana Isabel Marcos Navarro, Nerea Larrañaga, Joseba Bidaurrazaga, Arantza Lopez-de-Munain, Rafael Marcos-Gragera, Àngel Izquierdo, Loreto Vilardell, María José Sánchez, Elena Molina-Portillo, Miguel Rodríguez-Barranco, Josefina Perucha, Paula Franch, Maria Ramos, Carmen Navarro, María Dolores Chirlaque, Diego Salmerón, Eva Ardanaz, Marcela Guevara, Rosana Burgui, Jaume Galceran, Alberto Ameijide, Marià Carulla, Jàmnica Bigorra, Rafael Peris Bonet, Elena Pardo
An independent survival prognostic role for human epidermal growth factor receptor 2 in gastric cancer: evidence from a meta-analysis
Y. Wang, L. He, Y. Cheng
Treatment strategies for rectal cancer with synchronous liver metastases: surgical and oncological outcomes with propensity-score analysis
H. Salvador-Rosés, S. López-Ben, P. Planellas, E. Canals, M. Casellas-Robert, R. Farrés, E. Ramos, A. Codina-Cazador, J. Figueras
The prognostic impact of additional intrathoracic findings in patients with cancer-related pulmonary embolism
P. Jiménez-Fonseca, A. Carmona-Bayonas, C. Font, J. Plasencia-Martínez, D. Calvo-Temprano, R. Otero, C. Beato, M. Biosca, M. Sánchez, M. Benegas, D. Varona, L. Faez, M. Antonio, I. de la Haba, O. Madridano, M. P. Solis, A. Ramchandani, E. Castañón, P. J. Marchena, M. Martín, F. Ayala de la Peña, V. Vicente
Bevacizumab plus chemotherapy for patients with advanced pulmonary adenocarcinoma harboring EGFR mutations
R.-L. Chen, H.-J. Chen, B.-Y. Jiang, X.-C. Zhang, Q. Zhou, H.-Y. Tu, W.-Z. Zhong, Y.-L. Wu, J.-J. Yang
Histopathological factors predicting response to neoadjuvant therapy in gastric carcinoma
M. L. Sánchez de Molina, C. Díaz del Arco, P. Vorwald, D. García-Olmo, L. Estrada, M. J. Fernández-Aceñero